We are live on !
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter Est. Return
-11.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.06B
AUM Growth
+$226M
(+8%)
Cap. Flow
+$653M
Cap. Flow % of AUM
Cap. Flow %
21.38%
Top 10 Holdings %
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$334M |
| 2 |
JD.com
JD
|
+$84.6M |
| 3 |
Baidu
BIDU
|
+$84.3M |
| 4 |
NetEase
NTES
|
+$50.9M |
| 5 |
Pinduoduo
PDD
|
+$50.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NIO
NIO
|
+$10.7M |
| 2 |
Kingsoft Cloud Holdings
KC
|
+$9.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.55M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.48M |
| 5 |
Hello Group
MOMO
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 63.45% |
| 2 | Communication Services | 21.89% |
| 3 | Technology | 6.77% |
| 4 | Healthcare | 2.16% |
| 5 | Financials | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Copart
CPRT
$25.8B
| $328K | 0.01% |
10,464
-208
| -2% | -$6.6K |
2021 Q1
4 quarters
|
|
177
NextEra Energy
NEE
$166B
| $324K | 0.01% |
3,828
-501
| -12% | -$40.2K |
2021 Q1
4 quarters
|
|
178
CareDx
CDNA
$3.31B
| $322K | 0.01% |
+8,715
| New | +$340K |
2022 Q1
0 quarters
|
|
179
Arcturus Therapeutics
ARCT
$294M
| $321K | 0.01% |
+11,910
| New | +$304K |
2022 Q1
0 quarters
|
|
180
Linde
LIN
$230B
| $319K | 0.01% |
1,000
-135
| -12% | -$41.7K |
2021 Q1
4 quarters
|
|
181
Intellia Therapeutics
NTLA
$1.6B
| $318K | 0.01% |
+4,377
| New | +$371K |
2022 Q1
0 quarters
|
|
182
Zscaler
ZS
$33.8B
| $318K | 0.01% |
1,316
| – | – |
2021 Q4
1 quarter
|
|
183
BridgeBio Pharma
BBIO
$13B
| $317K | 0.01% |
+31,264
| New | +$321K |
2022 Q1
0 quarters
|
|
184
Vir Biotechnology
VIR
$1.69B
| $316K | 0.01% |
+12,283
| New | +$364K |
2022 Q1
0 quarters
|
|
185
DELISTED
Apellis Pharmaceuticals
APLS
| $315K | 0.01% |
+6,196
| New | +$274K |
2022 Q1
0 quarters
|
|
186
Veracyte
VCYT
$3.47B
| $311K | 0.01% |
+11,276
| New | +$323K |
2022 Q1
0 quarters
|
|
187
Fate Therapeutics
FATE
$214M
| $310K | 0.01% |
7,996
+4,468
| +127% | +$173K |
2021 Q4
1 quarter
|
|
188
Ionis Pharmaceuticals
IONS
$7.14B
| $309K | 0.01% |
+8,334
| New | +$273K |
2022 Q1
0 quarters
|
|
189
Halozyme
HALO
$13.8B
| $308K | 0.01% |
7,726
+2,699
| +54% | +$96.1K |
2021 Q4
1 quarter
|
|
190
United Parcel Service
UPS
$82.9B
| $305K | 0.01% |
1,423
-184
| -11% | -$39.1K |
2021 Q1
4 quarters
|
|
191
Twist Bioscience
TWST
$8.8B
| $303K | 0.01% |
+6,126
| New | +$340K |
2022 Q1
0 quarters
|
|
192
Emergent Biosolutions
EBS
$327M
| $302K | 0.01% |
+7,354
| New | +$324K |
2022 Q1
0 quarters
|
|
193
DELISTED
Blueprint Medicines
BPMC
| $300K | 0.01% |
+4,698
| New | +$337K |
2022 Q1
0 quarters
|
|
194
Keysight
KEYS
$56.4B
| $300K | 0.01% |
1,901
+111
| +6% | +$18.5K |
2021 Q1
4 quarters
|
|
195
DELISTED
Exact Sciences
EXAS
| $299K | 0.01% |
+4,275
| New | +$312K |
2022 Q1
0 quarters
|
|
196
Inovio Pharmaceuticals
INO
$102M
| $299K | 0.01% |
6,942
+4,561
| +192% | +$205K |
2021 Q1
4 quarters
|
|
197
Karyopharm Therapeutics
KPTI
$8.85M
| $299K | 0.01% |
2,705
+1,879
| +227% | +$234K |
2021 Q1
4 quarters
|
|
198
DELISTED
Dynavax Technologies
DVAX
| $298K | 0.01% |
27,513
+14,567
| +113% | +$177K |
2021 Q4
1 quarter
|
|
199
Ultragenyx Pharmaceutical
RARE
$1.43B
| $298K | 0.01% |
+4,101
| New | +$285K |
2022 Q1
0 quarters
|
|
200
Arrowhead Research
ARWR
$7.9B
| $295K | 0.01% |
+6,421
| New | +$318K |
2022 Q1
0 quarters
|
|
Similar funds
E Fund Management's Q1 2022 Portfolio in Review
As of Q1 2022, E Fund Management held 374 positions worth $3.06B, up 8% from $2.83B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
E Fund Management deployed $653M of net new capital in Q1 2022, opening 73 new positions and adding to 133 existing holdings. Its largest new stake was Natera: 6,882 shares worth $280K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, up from 61% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was United States Brent Oil Fund, an estimated $6.01M trimmed.
- E Fund Management's largest Q1 2022 buy was Natera: 6,882 shares worth $280K.
- E Fund Management added most to Alibaba in Q1 2022, an estimated $334M increase.
- E Fund Management's biggest Q1 2022 reduction was United States Brent Oil Fund, cutting an estimated $6.01M.
- E Fund Management fully exited NIO in Q1 2022, selling an estimated $10.7M.
- E Fund Management's ten largest holdings make up 83% of its $3.06B portfolio in Q1 2022.
- E Fund Management opened 73 new positions and closed 49 in Q1 2022.
- E Fund Management's portfolio value rose 8% quarter-over-quarter to $3.06B.
Based on E Fund Management's 13F filing for Q1 2022, filed 12 May 2022.